Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)
South Korea
· Delayed Price · Currency is KRW 5,430.00
-250.00 (-4.40%)
At close: Mar 9, 2026
Sinsin Pharmaceutical Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 6, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 82,376 | 82,376 | 94,664 | 84,651 | 97,850 | 138,658 | Upgrade
|
| Market Cap Growth | 3.23% | -12.98% | 11.83% | -13.49% | -29.43% | 34.02% | Upgrade
|
| Enterprise Value | 124,888 | 122,361 | 135,899 | 130,024 | 145,574 | 183,301 | Upgrade
|
| Last Close Price | 5430.00 | 5354.84 | 6085.51 | 5387.79 | 6171.41 | 8745.23 | Upgrade
|
| PE Ratio | 12.68 | 16.85 | 20.23 | 19.18 | - | 382.34 | Upgrade
|
| PS Ratio | 0.75 | 0.77 | 0.92 | 0.92 | 1.32 | 2.07 | Upgrade
|
| PB Ratio | 1.16 | 1.26 | 1.53 | 1.42 | 1.79 | 2.47 | Upgrade
|
| P/TBV Ratio | 1.16 | 1.26 | 1.53 | 1.43 | 1.80 | 2.49 | Upgrade
|
| P/FCF Ratio | 32.59 | 18.56 | - | 18.59 | - | - | Upgrade
|
| P/OCF Ratio | 15.68 | 13.86 | 24.09 | 15.50 | 4220.66 | 74.34 | Upgrade
|
| EV/Sales Ratio | 1.13 | 1.15 | 1.33 | 1.41 | 1.97 | 2.73 | Upgrade
|
| EV/EBITDA Ratio | 9.73 | 10.97 | 13.67 | 14.16 | 62.51 | - | Upgrade
|
| EV/EBIT Ratio | 14.51 | 17.76 | 22.64 | 23.96 | - | - | Upgrade
|
| EV/FCF Ratio | 49.42 | 27.57 | - | 28.56 | - | - | Upgrade
|
| Debt / Equity Ratio | 0.63 | 0.70 | 0.72 | 0.73 | 0.84 | 0.81 | Upgrade
|
| Debt / EBITDA Ratio | 3.47 | 4.09 | 4.48 | 4.73 | 19.85 | - | Upgrade
|
| Debt / FCF Ratio | 17.63 | 10.27 | - | 9.55 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.60 | 0.69 | 0.71 | 0.69 | 0.83 | 0.76 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.34 | 4.04 | 4.44 | 4.49 | 19.51 | -26.91 | Upgrade
|
| Net Debt / FCF Ratio | 16.94 | 10.15 | -40.84 | 9.06 | -17.09 | -4.22 | Upgrade
|
| Asset Turnover | 0.83 | 0.84 | 0.84 | 0.78 | 0.64 | 0.54 | Upgrade
|
| Inventory Turnover | 4.07 | 4.34 | 4.60 | 4.98 | 4.60 | 3.85 | Upgrade
|
| Quick Ratio | 0.62 | 0.56 | 0.59 | 0.71 | 0.76 | 0.77 | Upgrade
|
| Current Ratio | 0.95 | 0.87 | 0.91 | 1.06 | 1.08 | 1.15 | Upgrade
|
| Return on Equity (ROE) | 9.54% | 7.54% | 7.64% | 7.62% | -2.61% | 0.36% | Upgrade
|
| Return on Assets (ROA) | 4.05% | 3.39% | 3.06% | 2.88% | -0.72% | -2.11% | Upgrade
|
| Return on Invested Capital (ROIC) | 7.07% | 5.95% | 5.80% | 5.40% | -1.35% | -4.02% | Upgrade
|
| Return on Capital Employed (ROCE) | 11.70% | 9.80% | 8.30% | 6.90% | -1.70% | -5.00% | Upgrade
|
| Earnings Yield | 7.89% | 5.93% | 4.94% | 5.21% | -1.51% | 0.26% | Upgrade
|
| FCF Yield | 3.07% | 5.39% | -1.14% | 5.38% | -2.72% | -7.29% | Upgrade
|
| Dividend Yield | 1.06% | 1.12% | - | - | - | - | Upgrade
|
| Payout Ratio | 14.00% | 18.62% | 16.21% | - | - | 117.13% | Upgrade
|
| Buyback Yield / Dilution | -0.13% | - | - | - | - | - | Upgrade
|
| Total Shareholder Return | 0.93% | 1.12% | - | - | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.